Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study).
Zeuschner P, Hölters S, Stöckle M, Seliger B, Mueller A, Bachmann HS, Grünwald V, Christoph DC, Stenzl A, Grimm MO, Brüning F, Goebell PJ, Augustin M, Roos F, Harde J, Benz-Rüd I, Staehler M, Junker K.
Zeuschner P, et al. Among authors: bruning f.
Cancers (Basel). 2021 May 25;13(11):2594. doi: 10.3390/cancers13112594.
Cancers (Basel). 2021.
PMID: 34070677
Free PMC article.